dupilumab
Showing 1 - 25 of 97
Dupilumab in Prurigo Nodularis: An Observational Study
Not yet recruiting
- Prurigo Nodularis
- Dupilumab
- (no location specified)
Aug 7, 2023
Bullous Pemphigoid Trial (dupilumab)
Temporarily not available
- Bullous Pemphigoid
- dupilumab
- (no location specified)
Jun 7, 2023
Chronic Rhinosinusitis With Nasal Polyps Trial in Charleston, Charlottesville (Dupilumab)
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Dupilumab
-
Charleston, South Carolina
- +1 more
Jul 27, 2023
Dermal Hypersensitivity Reaction Trial in Ann Arbor (Dupilumab)
Not yet recruiting
- Dermal Hypersensitivity Reaction
- Dupilumab
-
Ann Arbor, MichiganUniversity of Michigan
Aug 21, 2023
Atopic Dermatitis Trial in San Francisco (Dupilumab)
Recruiting
- Atopic Dermatitis
- Dupilumab
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 4, 2023
Atopic Dermatitis, Atopic Dermatitis Eczema Trial in Rotterdam (Dupilumab)
Not yet recruiting
- Atopic Dermatitis
- Atopic Dermatitis Eczema
- Dupilumab
-
Rotterdam, Zuid-Holland, NetherlandsErasmus Medical Center
Aug 22, 2023
Eosinophilic Oesophagitis Trial (Dupilumab, Placebo)
Not yet recruiting
- Eosinophilic Oesophagitis
- Dupilumab
- Placebo
- (no location specified)
Oct 19, 2023
Skin Diseases Trial in Chicago (Dupilumab)
Not yet recruiting
- Skin Diseases
- Dupilumab
-
Chicago, IllinoisAnn & Robert H. Lurie Children's Hospital of Chicago
Jan 9, 2023
Asthma, Allergic Trial in San Antonio (Dupilumab, House Dust Mites (HDM), Placebo)
Not yet recruiting
- Asthma, Allergic
- Dupilumab
- +2 more
-
San Antonio, Texas
- +1 more
Jan 27, 2023
Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema Trial in San Francisco (Dupilumab)
Recruiting
- Atopic Dermatitis
- +3 more
- Dupilumab
-
San Francisco, CaliforniaUCSF Psoriasis and Skin Treatment Center
Jan 25, 2023
Dermatitis Atopic Trial (dupilumab)
Not yet recruiting
- Dermatitis Atopic
- dupilumab
- (no location specified)
Aug 1, 2023
Alopecia Areata Trial in United States (Dupilumab, Placebo)
Not yet recruiting
- Alopecia Areata
- Dupilumab
- Placebo
-
Irvine, California
- +3 more
May 10, 2023
Atopic Dermatitis Trial in Newark (BSI-045B, Dupilumab)
Not yet recruiting
- Atopic Dermatitis
- BSI-045B
- Dupilumab
-
Newark, DelawareBiosion USA, Inc.
Jul 7, 2023
Atopic Dermatitis, Atopic Dermatitis Eczema Trial in San Francisco (Dupilumab)
Completed
- Atopic Dermatitis
- Atopic Dermatitis Eczema
- Dupilumab
-
San Francisco, CaliforniaUCSF Psoriasis and Skin Treatment Center
Jan 5, 2023
Atopic Dermatitis Trial (Dupilumab)
Not yet recruiting
- Atopic Dermatitis
- Dupilumab
- (no location specified)
Dec 26, 2022
Moderate-to-Severe Atopic Dermatitis, Atopic Eczema Trial (dupilumab, Topical emollient (moisturizer))
Not yet recruiting
- Moderate-to-Severe Atopic Dermatitis
- Atopic Eczema
- dupilumab
- Topical emollient (moisturizer)
- (no location specified)
Oct 18, 2022
Colitis Ulcerative Trial in Miami Lakes, Charlotte (Dupilumab, Placebo)
Recruiting
- Colitis Ulcerative
- Dupilumab
- Placebo
-
Miami Lakes, Florida
- +1 more
Feb 15, 2023
Dupilumab in Patients With Bullous Pemphigoid
Recruiting
- Bullous Pemphigoid
- Dupilumab
-
Beijing, Beijing, ChinaPeking University First Hospital
Dec 13, 2022
Hand Eczema Trial in Groningen (Dupilumab, Placebo)
Active, not recruiting
- Hand Eczema
- Dupilumab
- Placebo
-
Groningen, NetherlandsUniversity Medical Center Groningen
Aug 18, 2022
Atopic Dermatitis Trial in Guangzhou (Dupilumab)
Not yet recruiting
- Atopic Dermatitis
- Dupilumab
-
Guangzhou, Guangdong, ChinaDermatology Hospital of Southern Medical University (Guangdong P
Nov 25, 2022
Keloid Trial in New York (Dupilumab, Placebo)
Recruiting
- Keloid
- Dupilumab
- Placebo
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Aug 16, 2022
Alopecia Areata Trial in New York, Rochester (Dupilumab, Placebo)
Not yet recruiting
- Alopecia Areata
- Dupilumab
- Placebo
-
New York, New York
- +1 more
Sep 20, 2022
Chronic Sinusitis Trial in Baltimore (dupilumab, )
Recruiting
- Chronic Sinusitis
- dupilumab
- placebo
-
Baltimore, MarylandJohns Hopkins University School of Medicine
Oct 12, 2022
Chronic Rhinosinusitis With Nasal Polyps Trial in China (Dupilumab, Placebo, Budesonide)
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Dupilumab
- +2 more
-
Beijing, China
- +9 more
May 31, 2023
Allergies Food Milk Trial in Phoenix, Scottsdale, Mountain View (Dupilumab, Placebo)
Recruiting
- Allergies Food Milk
- Dupilumab
- Placebo
-
Phoenix, Arizona
- +2 more
Nov 28, 2022